Liyu Liang

A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TPN171H, a Novel Phosphodiesterase Type 5 Inhibitor, in Healthy Subjects

Jingshan Shen, Zhen Wang, Guanghui Tian, 2021, Drug design, development and therapy.

Fetuin A promotes lipotoxicity in β cells through the TLR4 signaling pathway and the role of pioglitazone in anti-lipotoxicity

Liyong Yang, Sunjie Yan, Ximei Shen, 2015, Molecular and Cellular Endocrinology.

The effect of FFAR1 on pioglitazone-mediated attenuation of palmitic acid-induced oxidative stress and apoptosis in βTC6 cells.

Liyong Yang, Sunjie Yan, Ximei Shen, 2014, Metabolism: clinical and experimental.

Evaluation of three BMI criteria performance to diagnose obesity in a Chinese population

Liyong Yang, Sunjie Yan, Yongze Zhang, 2016, International Journal of Diabetes in Developing Countries.

A single-dose, randomized crossover study in healthy Chinese subjects to evaluate pharmacokinetics and bioequivalence of two capsules of calcium dobesilate 0.5 g under fasting and fed conditions

Jingying Jia, Yan-mei Liu, Mei-Xian Ou, 2023, PloS one.